Journal of Advances In Allergy & Immunologic Diseases
Call Us: +1 6469050407
  editor@siftdesk.org Sign In | Register
  • Home
  • About Us
  • Journals
  • Guidelines
    • Author Guidelines
    • Editor Guidelines
    • Reviewer Guidelines
  • Policies
    • Publication Ethics
    • Peer Review
    • Open Access
    • Terms & Conditions
Logo
  • Journal Home
  • Special Issue Topics
  • Article In Press
  • Current Issue
  • Archive
  • Submit Manuscript
  • Editorial Members
  • Indexing Archive
  • Processing Fee

© 2010 - 2020 Copyright Sift Desk Journals. All Rights Reserved

profile

Journal of Advances In Allergy & Immunologic Diseases

Journal of Advances In Allergy & Immunologic Diseases(JAAID)

ISSN: 2575-6184

Impact Factor: 0.431

Novel Therapeutic Strategies for Chronic HBV Infection: an Immunological Perspective

Submit Manuscript on this topic
Indexed Articles

Description

Chronic hepatitis B (CHB) is a life-threatening liver disease affecting 257 million people worldwide, in particular in the Asia-Pacific regions. In endemic areas, hepatitis B virus (HBV) is usually transmitted from chronically infected mothers to neonates. Perinatal HBV infection causes chronic infection in more than 90% of exposed individuals. With perinatal infection, lifetime mortality risk due to complications of liver cirrhosis (LC) or hepatocellular carcinoma (HCC) reaches up to 40% in men and 15% in women.

For the treatment of chronic HBV infection, nucleos(t)ide analogue antivirals have been successfully used to suppress viral replication. However, HBV exists as a cccDNA, which cannot be eliminated by nucleos(t)ide analogues. Therefore, a practical goal of novel HBV therapeutics can be HBs seroconversion (loss of HBsAg and development of HBsAg-specific antibodies), which occurs during spontaneous recovery from acute HBV infection. This HBs seroconversion is referred to as “functional cure” of HBV infection. When functional cure is reached, HBsAg-specific antibodies have virus-neutralizing activity and control HBV infection even in the presence of cccDNA. Currently, peg-IFN-α is often used to induce HBs seroconversion in patients with chronic HBV infection; however, the efficacy is not satisfactory. In future, other immunological therapeutics must be considered to achieve HBs seroconversion, including therapeutic vaccines and immune checkpoint blockers.

This Research Topic covers the mechanisms of immune dysfunction in chronic HBV infection and novel therapeutic approaches to overcome it. We welcome the submission of Original Research articles, Case Report, Review, Opinion, Perspective, Systematic Review, and Correction which cover the following topics:

1. Mechanisms of dysfunctional Innate and adaptive immune response in chronic HBV infection (interferon and cytokine response, T cell response, NK cell response, B cell response, NKT cell response, regulatory T cells and myeloid-derived suppressor cells, monocyte and macrophages)
2. Ways to overcome immune dysfunction – boosting interferon response
3. Ways to overcome immune dysfunction – boosting T & NK cell response
4. Ways to overcome immune dysfunction – various therapeutic vaccines
5. Ways to overcome immune dysfunction – immune checkpoint blockers

Keywords

hepatitis B virus, innate immunity, adaptive immunity, antigen-specific immune response, treatment


Journal Archive

Volume: 3 Issue: 1 Volume: 2 Issue: 1 Volume: 1 Issue: 1

Journal Recent Articles

Author: Alhassan Hussaini Mohammed
The Differentiation and Roles of inflammatory Cytokine in the initiation of Inflammatory Bowel Diseases (IBD)
Author: Dr. ALHASSAN Hussain
The Regulations of Gene Expressions by 1α,25(OH)2D3 in Patients with Inflammatory Bowel Diseases
Author: Dr. ALHASSAN Hussain
PROFILE OF INTERLEUKIN-1β IN CERVICAL CANCER PATIENTS ATTENDING ONCOLOGY UNIT, USMANU DANFODIYO UNIVERSITY TEACHING HOSPITAL, SOKOTO-NIGERIA.
Author: Tsvetelina Velikova
Increased percentages of Th17 cells showed an association with poorly controlled bronchial asthma in the childhood
Author: Fulvia Gloria-Bottini
IMMUNE RELATED DISEASES AND THEIR RELATIONSHIP WITH THE GENETIC VARIABILITY WITHIN THE ADENOSINE DEAMINASE GENE
Author: ANA LÚCIA MORENO AMOR
ENTEROPARASITES, RESPIRATORY ALLERGY AND OTHER SIGNS AND SYMPTOMS IN CHILDS AND YOUTH POPULATION OF RECÔNCAVO OF BAHIA – BRAZIL
Author: Bassey E. Bassey
OPTIMAL CONTROL MODEL FOR IMMUNE EFFECTORS RESPONSE AND MULTIPLE CHEMOTHERAPY TREATMENT (MCT) OF DUAL DELAYED HIV - PATHOGEN INFECTIONS
Author: Daniel Teshome Gebeyehu
A Review on Sheep pulmonary Adenocarcinoma
Author: Rodney P Jones
Outbreaks of a presumed infectious pathogen creating on/off switching in deaths
Author: Yihong Hu
Nucleic Acid Sequence-Based Amplification in Diagnosis of Disease Pathogens
Author: Ozlem Sancakli
Proctocolitis in a child treated with oral immunotherapy for cow’s milk allergy
Author: Humaa Bhatti
Participation in Multidisciplinary Team Clinic Results in Improved Outcomes in Inner City Asthmatic Children
Author: Ken-ichi Isobe
Murine model of obesity-induced type II diabetes by GADD34 (PPP1R15A) and other phosphatase 1 regulatory subunits deficiency.
Author: Merritt Fajt MD
Atypical DRESS Syndrome in a Post-Partum Patient
Author: Merritt Fajt MD
Non-ionic Contrast Allergy Manifesting as Stevens Johnson Syndrome and Erythema Multiforme

CONTACT US

Sift Desk Journals,
#591, 600 Madison Ave,
NY, 10022, USA
Call Us: +16469050407
info@siftdesk.org

JOURNALS LINKS

  • Food Science
  • Environmental Studies
  • Computational Chemistry
  • Chemical Engineering
  • Anesthesia & Surgery
  • Cellular & Molecular Physiology
  • Plant Science
  • Aquaculture & Fish Science
  • Nano Technology & Materials Science
  • Allergy & Immunology

QUICK CONTACT

Sift Desk Journals